Totally proposes full year dividend of 0.25p following strong results
(AIM:TLY ) has looked back on a ‘good year’ in its final results for the 12-month period ended 31 March 2020.
The healthcare services provider reported a revenue of £105.9m for the 12 months to 31 March 2020, up from £78.0m.
During the period in June 2019, the company successfully completed its acquisition of Greenbrook Healthcare which increased its presence across London in Urgent Care.
The group also posted a 265% increase in EBITDA, excluding exceptional costs relating to the acquisition and impairment of goodwill, totalling £4.0m.
The group said it expects continued growth in operating cash flow and as at 31 March 2020, cash was up 19% to £8.9m from £7.5m in the previous period.
The Group is cash generative and responded with the distribution of its maiden dividend in February 2020 and has proposed a maiden final dividend of 0.25p per share taking the total dividends for the year to 0.50p. Totally said this accurately reflects its efforts to ensure it delivers operationally across the business.
Shares in Totally have increased more than 50% over the past three months and trading at 17.75p following publication of its results.
Bob Holt, Chairman of Totally, has described the period as “a good year” which delivered profit during times of unrivalled political instability and the recent COVID-19 pandemic.
“Totally's strategy has always been to support the NHS to manage the pressures and demands placed upon healthcare services.
The COVID-19 pandemic is no exception, and everyone at Totally has stood shoulder to shoulder with the NHS and delivered patient-facing services throughout this period and continues to do so,” he said.
Wendy Lawrence, Chief Executive Officer of Totally added that Totally remains “well positioned to further build on our market-leading positions in all of our divisions.”
Looking ahead, Holt commented, “What is very clear to the Board of Totally is that our strategy has been, and continues to be, correctly focused during these unprecedented times.”
Follow News & Updates from here:
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.